Home
Drugs
Tacrolimus
Clinical Trials

Clinical Trials Related to Tacrolimus

Related studies linked through entity extraction aliases.

Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders

Status: TERMINATED
Phase: PHASE2

A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease

Status: COMPLETED
Phase: NA

Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

Status: COMPLETED
Phase: PHASE3

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

Status: COMPLETED
Phase: PHASE2

Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

Status: TERMINATED
Phase: PHASE4

Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Status: COMPLETED
Phase: PHASE3

Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys

Status: COMPLETED
Phase: PHASE3

Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts

Status: COMPLETED
Phase: PHASE3

A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients

Status: COMPLETED
Phase: PHASE4

Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

Status: COMPLETED
Phase: PHASE2

Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma

Status: COMPLETED
Phase: PHASE2

Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

Status: TERMINATED
Phase: PHASE3

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Status: COMPLETED
Phase: PHASE3

FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

Status: COMPLETED
Phase: PHASE3

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Status: COMPLETED
Phase: PHASE1

Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis

Status: WITHDRAWN
Phase: NA

Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy

Status: COMPLETED
Phase: NA

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Status: COMPLETED
Phase: PHASE1

Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Status: WITHDRAWN
Phase: PHASE2

Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients

Status: COMPLETED
Phase: PHASE4